Alps Medical Breakthroughs ETF (NY: SBIO )
50.28 USD -1.32 (-2.56%) Streaming Delayed Price Updated: 4:25 PM EST, Mar 8, 2021 Add to My Watchlist
All news about Alps Medical Breakthroughs ETF
Small Caps Taking Charge Of The Bulls: 6 ETF Winners YTD
January 22, 2019
Here are six top performing small-cap ETFs of the current rally that have gained in double digits and will continue their outperformance.
Biotech ETFs Surge After Eli Lilly Buys Out Loxo Oncology
January 07, 2019
Biotechnology stocks and sector-related ETFs were among the best performers Monday after Eli Lilly (NYSE: LLY) said it will acquire Loxo Oncology Inc. (NasdaqGS: LOXO) for $8 billion. Among the best...
8 Small-Cap ETFs & Stocks Crushing Russell 2000
May 21, 2018
Presenting 8 ETFs and stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance.
A Spread of ETFs to Mimic Hedge Fund Ideas
May 21, 2018
Hedge Fund “Hot Dogs," which are defined as stocks that capture the maximum hedge-fund dollars, centers around the technology, media and Internet sectors.
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign countries to pay less on American-manufactured...
Don't Bail On Biotech ETFs: 'There Are Several Reasons Why The Sector Took A Breather'
March 09, 2018
The broader market scuffled in February, but the health care sector was worse. For example, the Health Care Select Sector SPDR (NYSE: ...
A Nifty Biotech ETF Idea for 2018
January 11, 2018
Biotechnology stocks bolstered the broader healthcare sector last year, a theme that is expected to continue in 2018. Investors looking for a way to access potentially smaller biotechnology companies...
Top Sector ETFs of 2017
December 25, 2017
As we are approaching the end of 2017, it’s time to look back at the hot investing areas of 2017. This is especially true as this year has treated the broader market well.
High Beta ETFs & Stocks For Market-Beating Returns
October 05, 2017
Given the bullish trends, high-beta products will continue to generate outsized returns in the coming weeks and is suitable for risk-tolerant investors given its volatile nature.
Biotech ETFs Soar On Gilead-Kite Deal
August 29, 2017
Through ETF ways, investors get to play the overall evolvement of the biotech space and certain downbeat VGM scores of GILD and KITE would not come in the way of investors’ optimism.
Biotech ETFs Jump on Gilead, Kite Deal
August 28, 2017
The biotechnology segment rallied Monday with small-cap biotech names and related exchange traded funds leading the charge after Gilead Sciences (NasdaqGS: GILD) acquired Kite Pharma (NasdaqGS: KITE)....
Best & Worst Weekly Performers: June 24 Edition
June 24, 2017
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as...
Healthcare ETFs Are Latest Victim to Trump
January 11, 2017
Healthcare stocks, especially the biotech segment, and related exchange traded funds plunged Wednesday after President-elect Donald Trump singled out the rising drug prices at a press conference. The...
Biotechnology stocks and sector-related exchange traded funds surged Wednesday as Vice President-elect Mike Pence stated that President-elect Donald Trump’s “first order of business” was to repeal the...
Rising Rates May Hurt Small-Cap Biotech ETF Valuations
December 23, 2016
The Federal Reserve has hiked interest rates for the second time in a decade and plans to raise rates three more times next year. With higher interest rates, investors may find small-cap biotechnology...
5 Reasons to Buy 5 Low P/E Biotech ETFs
November 14, 2016
With Trump winning the U.S. presidential election, the biotech and pharma sectors have regained their lost ground.
ETFs & Stocks That Topped Or Flopped After Trump Won
November 10, 2016
ETF Winners and Losers of President-Elect Trump
November 09, 2016
Biotechnology and pharmaceutical sector exchange traded funds were the clear winners as Republicans swept the U.S. elections, easing concerns that Democrats would implement controls on drug prices. On...
Top ETF Stories Of October
November 01, 2016
The month of October was highlighted by a deluge of earnings, Fed hike speculation and presidential debates on the domestic front. The bottom line of the S&P 500, in fact, returned to growth after...
ETF Performance Report: October
November 01, 2016
The equities market and stock exchange traded funds ended October flat in muted action as a renewed FBI investigation into Democratic runner Hillary Clinton’s emails added to political risk with just a...
4 Frightful ETFs Of This Year
October 27, 2016
Solar stocks are victims of the general misconception that oil price and solar market fundamentals are directly related to each other. Further, weak earnings from a few industry bellwethers weighed on...
Same as many other biopharmaceutical stocks, Sarepta Therapeutics Inc (NASDAQ: SRPT) ad a rocky start to the year. However, its luck ...
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
October 13, 2016
The past few months have been great for small cap bluebird bio Inc (NASDAQ: BLUE), which saw its stock appreciate more than 47.6 percent ...
M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound
September 12, 2016
A large acquisition and favorable results from a drug trial helped biotechnology and pharmaceutical sector-related exchange traded funds rally on Monday. Among the best performing ETFs of Monday, the...
Pfizer Acquires Medivation, Renews Biotech M&A Bets
August 22, 2016
Pfizer (NYSE: PFE) announced a $14 billion deal to acquire cancer drug developer Medivation (NasdaqGS: MDVN), propelling the broader biotechnology exchange traded funds higher on speculation of more...
BBP: An Outperforming Biotechnology ETF
July 21, 2016
The BioShares Biotechnology Products Fund (NasdaqGM: BBP) has capitalized on a string of acquisitions and outperformed other biotechnology- and pharmaceuticals-related exchange traded funds. BBP, which...
Biotech ETFs Rally as Earnings Boost Optimism
July 20, 2016
U.S. equities strengthened Wednesday with biotechnology stocks and sector-related exchange traded funds leading the charge on better-than-expected second quarter results. On Wednesday, the iShares...